Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family

Carcinogenesis
Giulia CiniAlessandra Viel

Abstract

Lynch syndrome (LS) is an inherited predisposition cancer syndrome, typically caused by germline mutations in the mismatch repair genes MLH1, MSH2, MSH6 and PMS2. In the last years, a role for epimutations of the same genes has also been reported. MLH1 promoter methylation is a well known mechanism of somatic inactivation in tumors, and more recently, several cases of constitutional methylation have been identified. In four subjects affected by multiple tumors and belonging to a suspected LS family, we detected a novel secondary MLH1 gene epimutation. The methylation of MLH1 promoter was always linked in cis with a 997 bp-deletion (c.-168_c.116+713del), that removed exon 1 and partially involved the promoter of the same gene. Differently from cases with constitutional primary MLH1 inactivation, this secondary methylation was allele-specific and CpGs of the residual promoter region were totally methylated, leading to complete allele silencing. In the colon tumor of the proband, MLH1 and PMS2 expression was completely lost as a consequence of a pathogenic somatic point mutation (MLH1 c.199G>A, p.Gly67Arg) that also abrogated local methylation by destroying a CpG site. The evidences obtained highlight how MLH1 mutations and epimut...Continue Reading

References

Mar 18, 1994·Science·N PapadopoulosM D Adams
Nov 9, 2002·Bioinformatics·Long-Cheng Li, Rajvir Dahiya
Nov 16, 2005·Gastroenterology·Megan HitchinsRobyn Ward
Jan 29, 2009·International Journal of Cancer. Journal International Du Cancer·Annette GyllingPaivi Peltomäki
Sep 16, 2009·Carcinogenesis·Shikhar SharmaPeter A Jones
Jan 18, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Chiara PastrelloAlessandra Viel
Jun 7, 2011·JAMA : the Journal of the American Medical Association·Valérie BonadonaUNKNOWN French Cancer Genetics Network
Jun 30, 2011·Journal of Medical Genetics·Monika MorakUNKNOWN German HNPCC consortium
Sep 9, 2011·Breast Cancer Research and Treatment·Barbara BernasconiMaria Grazia Tibiletti
Oct 20, 2011·Nature Reviews. Gastroenterology & Hepatology·Victoria Valinluck Lao, William M Grady
May 30, 2012·Nature Reviews. Genetics·Peter A Jones
Jul 6, 2012·European Journal of Human Genetics : EJHG·Marta PinedaGabriel Capellá
Jul 14, 2012·Cancer Cell·Jueng Soo You, Peter A Jones
Jul 20, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Aug 11, 2012·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Robyn L WardMegan P Hitchins
Oct 24, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christoph EngelHans F A Vasen
Dec 25, 2012·Familial Cancer·Marjolijn J L LigtenbergNicoline Hoogerbrugge
Mar 7, 2013·Familial Cancer·Megan P Hitchins
Aug 14, 2013·Biochimica Et Biophysica Acta·Marta KulisJosé I Martín-Subero
Dec 7, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Madhuri HegdeUNKNOWN Working Group of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee
Jan 22, 2014·Clinical Genetics·P Peltomäki
Dec 2, 2014·Epigenetics : Official Journal of the DNA Methylation Society·Francesca CrucianelliMaurizio Genuardi

❮ Previous
Next ❯

Citations

Sep 8, 2015·Epigenomics·Corina Nagy, Gustavo Turecki
Mar 26, 2016·Pharmacology & Therapeutics·Yingmei Zhang, Jun Ren
May 18, 2016·The American Journal of Surgical Pathology·Jaclyn C WatkinsLynette M Sholl
May 5, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Ileana CarnevaliMaria Grazia Tibiletti
Mar 23, 2019·Human Mutation·Paras Garg, Andrew J Sharp
Apr 1, 2020·Genes·Flavia CerratoAndrea Riccio
May 29, 2018·Nature Communications·Mafalda BarbosaAndrew J Sharp
Aug 7, 2020·Expert Review of Gastroenterology & Hepatology·Paivi PeltomäkiTaina T Nieminen
May 24, 2018·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Julie LeclercMarie-Pierre Buisine
Oct 5, 2018·British Journal of Cancer·Estela DámasoGabriel Capellá
May 3, 2021·Genes, Chromosomes & Cancer·Roman ZylaGulisa Turashvili
Jun 15, 2021·Current Oncology Reports·Danielle M Pastor, Jeffrey Schlom

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.